Norepinephrine bitartrate injection is indicated to raise blood pressure in adult patients with acute hypotension.

Bengaluru: Biocon has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received approval ...

This approval augments Biocon Pharma's complex injectables portfolio and reinforces its footprint in the US pharma market.

Norepinephrine bitartrate injection is a critical medication used to raise blood pressure in adult patients suffering from ...

Biocon's subsidiary has received approval from the US Food and Drug Administration (US FDA) for its ANDA Norepinephrine ...

Image Source: Zacks Investment Research Baxter launched a new 16 mg/250 mL dosage of Norepinephrine Bitartrate in 5% Dextrose injection, which is recommended for adult patients with severe ...

The approval covers the norepinephrine bitartrate injection 4 mg/4 mL (1 mg/mL) single-dose vial, which can now be ...

Biocon added 1.34% to Rs 348.55 after the company's wholly owned subsidiary Biocon Pharma announced the receipt of U.S Food and Drug Administration (US FDA) approval for its ANDA Norepinephrine ...

Biocon Pharma Limited receives FDA approval for Norepinephrine Bitartrate Injection USP, expanding its complex drug portfolio ...